No decrease in incidence of arthroscopic meniscectomy in a Canadian province

Abstract

PurposeArthroscopic meniscectomy (APM) is the most common procedure in orthopedic surgery, despite increasing evidence questioning its benefit over conservative management for treatment of degenerative meniscal tears. The purpose of this study is to determine the epidemiology and trends of APM in Saskatchewan, a Canadian province, over a 20 year period. MethodsPhysician billing codes were used to identify patients who underwent APM in Saskatchewan between January 1, 1998 and December 31, 2017. Records were obtained from eHealth Saskatchewan, a provincial health database. Data was analyzed for overall incidence and age‐specific trends of APM. ResultsA total of 35,099 APMs were performed during the study period. The population of Saskatchewan ranged from 992,314 to 1,150,782 (median 1,017,368) during this time interval, with 81 orthopedic surgeons performing APM. Overall incidence rate of APM did not change significantly over time. No decrease was observed in patients presumed to have degenerative tears (≥ 50 years). The number of meniscectomies in patients ≥ 50 years was significantly greater during the second decade of study compared to the first (OR 1.48, p < 0.01). Conversely, the increase in incidence rate among older patients was not statistically significant (R2 = 0.125, n.s.). ConclusionOverall incidence rate of APM in Saskatchewan has not decreased during the last 20 years. Furthermore, APM frequency increased over time for individuals ≥ 50 years. Several regional factors may have contributed to these findings, including the large proportion of Saskatchewan residents engaged in physically demanding work and barriers to accessing physiotherapy services. Given recent evidence disputing the benefit of APM over conservative measures, this study highlights the need for improved dissemination of evidence, as well as the importance of an individualized treatment plan to address patient‐specific factors. Level of evidenceLevel IV

The value of reducing arthroscopic partial meniscectomy in the treatment of degenerative meniscus tears: a budget impact analysis

“…Given these findings, we recommend at least adhering to the current guidelines to avoid unnecessary costs that might be better spent on proven cost-effective treatments. However, adherence to the current guidelines is still suboptimal for the treatment of degenerative meniscus tears (9;10;29). Therefore, improving the adherence to guidelines and furthering the reduction of APM from the treatment of degenerative meniscus tears could result in substantial cost savings.…”

Significant improvements in clinical outcome measures and patient satisfaction after combined all‐arthroscopic meniscal allograft transplantation and autologous chondrocyte implantation: A single‐centre longitudinal study

“…Meniscal injuries are a common diagnosis, with an estimated prevalence of 222 per 100,000 [1], often going hand-in-hand with cartilage lesions [2]. Despite advances in surgical meniscal restoration, numerous lesions remain irreparable [3], often necessitating meniscectomy [4][5][6], which can accelerate joint degeneration, leading to the development of osteoarthritis [7]. Meniscal allograft transplantation (MAT) and autologous chondrocyte implantation (ACI) are surgical interventions developed to address these conditions without resorting to arthroplasty.…”

"You're stuck in the middle here": A qualitative study of GPs' experiences of managing knee pain attributed to a degenerative meniscal tears

“…Numerous studies have also explored the barriers to implementing clinical guidelines for osteoarthritis in primary care (14), but none speci cally exploring practice related to DMTs. While there is overlap with osteoarthritis management there are also distinctions, for example, there exists a surgical treatment option for a DMT that is no longer recommended but has not been fully de-implemented (9).…”